Boule Diagnostics (publ) Year-end report January–December 2022
Boule Diagnostics – Invitation to presentation of the year-end report 2022
Change in number of shares and votes in Boule Diagnostics
Boule Diagnostics appoints Jan Benjaminson as interim CFO
Boule Diagnostics raises approximately SEK 150 million through a significantly oversubscribed rights issue
Boule receives CE mark according to IVDR Class B for two product lines
Trading of subscription rights commences Tuesday 15 November
Boule Diagnostics publishes prospectus in connection with its Rights Issue
Boule Diagnostics (publ) Interim report January–September 2022
Boule Diagnostics – Invitation to presentation of the interim report Q3 2022
Cision will store the added information in order to continuously be able to send you the information you’ve chosen to subscribe to. Read more about how Cision process personal data.
Search
Search on the page